Alirocumab prevents atrial fibrillation in hypertension and obese mice through alleviation of PCSK9 induced atrial remodeling by regulating arachidonic acid metabolism
Event:
ESC Congress 2025
Topic:
Atrial Stressors
Session:
Drivers and modifiers of atrial fibrillation
